Neurocrine Biosciences (NBIX) Stock Chart & Stock Price History → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free NBIX Stock Alerts $135.41 -1.25 (-0.91%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Neurocrine Biosciences Stock Price Performance5 Day Performance-4.18%1 Month Performance-2.88%3 Month Performance+2.44%6 Month Performance+14.57%Year-To-Date Performance+1.38%1 Year Performance+49.20% Receive NBIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 NBIX Stock Chart for Friday, May, 31, 2024 NBIX Chart by TradingView Neurocrine Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/30/2024$134.62$136.66+1.52%$137.06$133.31761,760 shs$13.75 billion05/29/2024$140.48$134.62-4.17%$136.37$131.901.48 million shs$13.55 billion05/28/2024$139.40$140.48+0.77%$141.73$139.07569,250 shs$14.14 billion05/27/2024$139.40$139.40$142.18$139.34423,900 shs$14.03 billion05/24/2024$140.51$139.40-0.79%$142.16$139.34423,935 shs$14.03 billion05/23/2024$139.43$140.51+0.77%$141.79$138.52612,856 shs$14.14 billion Get the Latest News and Ratings for NBIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. 05/22/2024$140.55$139.43-0.80%$145.78$137.761.17 million shs$14.03 billion05/21/2024$141.65$140.55-0.78%$142.71$139.51538,944 shs$14.14 billion05/20/2024$142.29$141.65-0.45%$143.05$139.77500,590 shs$14.26 billion05/17/2024$141.91$142.29+0.27%$142.86$140.51641,937 shs$14.32 billion05/16/2024$142.00$141.91-0.06%$142.30$140.17663,808 shs$14.28 billion05/15/2024$138.48$142.00+2.54%$142.19$138.90684,685 shs$14.29 billion05/14/2024$136.15$138.48+1.71%$138.73$134.81637,462 shs$13.94 billion05/13/2024$136.70$136.15-0.40%$138.56$135.23712,819 shs$13.70 billion05/10/2024$139.66$136.70-2.12%$141.00$136.11679,325 shs$13.76 billion05/09/2024$139.02$139.66+0.46%$140.60$138.95479,494 shs$14.05 billion05/08/2024$143.19$139.02-2.91%$143.54$138.15653,593 shs$13.99 billion05/07/2024$141.71$143.19+1.04%$143.86$140.90644,768 shs$14.41 billion05/06/2024$140.71$141.71+0.71%$143.57$140.55483,775 shs$14.26 billion05/03/2024$139.83$140.71+0.63%$141.69$139.25616,566 shs$14.00 billion05/02/2024$143.03$139.83-2.24%$144.09$139.64882,403 shs$13.91 billion05/01/2024$137.54$143.03+3.99%$145.22$136.011.60 million shs$14.23 billion04/30/2024$138.89$137.54-0.97%$140.47$137.34966,529 shs$13.69 billion04/29/2024$135.99$138.89+2.13%$139.37$136.05681,740 shs$13.82 billion04/26/2024$137.76$135.99-1.28%$138.61$135.17717,575 shs$13.53 billion04/25/2024$138.97$137.76-0.87%$139.37$136.06706,045 shs$13.71 billion04/24/2024$140.09$138.97-0.80%$144.70$138.01927,988 shs$13.83 billion04/23/2024$133.66$140.09+4.81%$145.00$139.221.61 million shs$13.94 billion04/22/2024$132.00$133.66+1.26%$134.18$131.79575,066 shs$13.30 billion04/19/2024$132.54$132.00-0.41%$133.65$130.13556,052 shs$13.14 billion04/18/2024$133.23$132.54-0.52%$134.20$131.00549,307 shs$13.19 billion04/17/2024$132.99$133.23+0.18%$134.44$131.36571,073 shs$13.26 billion04/16/2024$131.74$132.99+0.95%$135.17$131.491.03 million shs$13.23 billion04/15/2024$134.66$131.74-2.17%$137.00$131.52767,232 shs$13.11 billion04/12/2024$135.93$134.66-0.93%$137.78$134.63577,029 shs$13.40 billion04/11/2024$138.09$135.93-1.56%$138.67$135.28808,737 shs$13.53 billion04/10/2024$138.94$138.09-0.61%$140.54$137.99639,131 shs$13.74 billion04/09/2024$139.44$138.94-0.36%$141.38$138.00598,996 shs$13.83 billion04/08/2024$138.92$139.44+0.37%$139.68$137.72615,637 shs$13.88 billion04/05/2024$137.61$138.92+0.95%$139.75$136.03458,596 shs$13.82 billionTech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.04/04/2024$137.59$137.61+0.01%$140.43$136.741.02 million shs$13.69 billion04/03/2024$137.74$137.59-0.11%$140.19$137.36614,130 shs$13.69 billion04/02/2024$141.38$137.74-2.57%$140.61$136.12913,859 shs$13.71 billion04/01/2024$137.92$141.38+2.51%$141.73$136.85995,764 shs$14.07 billion03/29/2024$137.92$137.92$138.72$135.971.25 million shs$13.72 billion03/28/2024$137.83$137.92+0.07%$138.72$135.971.25 million shs$13.72 billion03/27/2024$141.16$137.83-2.36%$141.73$133.431.17 million shs$13.72 billion03/26/2024$140.25$141.16+0.65%$142.31$139.94594,680 shs$14.05 billion03/25/2024$141.43$140.25-0.83%$142.08$138.85498,306 shs$13.96 billion03/22/2024$143.74$141.43-1.61%$145.42$137.35938,508 shs$14.07 billion03/21/2024$140.65$143.74+2.20%$148.37$139.312.51 million shs$14.30 billion03/20/2024$140.87$140.65-0.16%$141.64$137.14653,029 shs$14.00 billion03/19/2024$139.44$140.87+1.03%$141.06$138.32754,518 shs$14.02 billion03/18/2024$139.10$139.44+0.24%$141.76$138.57664,650 shs$13.88 billion03/15/2024$139.16$139.10-0.04%$142.15$138.671.73 million shs$13.84 billion03/14/2024$141.80$139.16-1.86%$142.50$137.831.17 million shs$13.85 billion03/13/2024$137.74$141.80+2.95%$141.91$138.321.07 million shs$14.11 billion03/12/2024$138.61$137.74-0.63%$139.98$137.66639,870 shs$13.71 billion03/11/2024$139.22$138.61-0.44%$140.25$137.31616,799 shs$13.79 billion03/08/2024$135.33$139.22+2.87%$140.33$136.27998,711 shs$13.85 billion03/07/2024$132.25$135.33+2.33%$135.61$132.62728,303 shs$13.47 billion03/06/2024$133.67$132.25-1.06%$134.57$131.65623,780 shs$13.16 billion03/05/2024$133.12$133.67+0.41%$135.15$132.12878,234 shs$13.30 billion03/04/2024$131.30$133.12+1.39%$134.28$131.01962,863 shs$13.25 billion03/01/2024$130.40$131.30+0.69%$132.60$129.151.32 million shs$13.07 billion02/29/2024$134.66$130.40-3.16%$136.10$130.041.72 million shs$12.98 billion Related Companies: Bio-Techne Stock Chart Qiagen Stock Chart CRISPR Therapeutics Stock Chart Denali Therapeutics Stock Chart Adaptive Biotechnologies Stock Chart Biogen Stock Chart Alnylam Pharmaceuticals Stock Chart BioMarin Pharmaceutical Stock Chart Incyte Stock Chart United Therapeutics Stock Chart Receive NBIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NBIX) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.